Karachaliou, N., Codony-Servat, J., Teixidó, C., Pilotto, S., Drozdowskyj, A., Codony-Servat, C., . . . Rosell, R. (2023). Author Correction: BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer. Nature Portfolio.
Chicago Style (17th ed.) CitationKarachaliou, Niki, et al. Author Correction: BIM and MTOR Expression Levels Predict Outcome to Erlotinib in EGFR-mutant Non-small-cell Lung Cancer. Nature Portfolio, 2023.
MLA (9th ed.) CitationKarachaliou, Niki, et al. Author Correction: BIM and MTOR Expression Levels Predict Outcome to Erlotinib in EGFR-mutant Non-small-cell Lung Cancer. Nature Portfolio, 2023.
Warning: These citations may not always be 100% accurate.